Changing the way diseases are treated, Arrowhead pharmaceuticals uses innovative, scientific methods to discover, develop, and deliver therapies and solutions.

Check out the development of Arrowhead’s products to treat challenging cardiometabolic, pulmonary, neuromuscular, liver, and more types of diseases.

The Investor Relations website contains information about Arrowhead Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.

Learn more about Arrowhead Pharmaceutical's foundation as a therapeutic discovery company, innovative use of RNAi, and ambitious pipeline for developing medicines.

Join Arrowhead and collaborate with our innovative experts. Let's push the boundaries of science and redefine the treatment of difficult diseases together.

See Arrowhead's scientific and innovative discovery and development platform, producing effective new therapies that are cost effective and may have a lower risk.

Arrowhead is committed to bringing new investigational medicines to patients with serious diseases as quickly and efficiently as possible. The company has established an expanded …

Stay up to date on Arrowhead Pharmaceutical's latest news, stories, and events. Read about recent studies on potential treatments, healthcare conferences, and more!

Nov 26, 2024 · Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT). Upon …

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-INHBE, the company’s investigational RNA …